
- Reports and Whitepapers
CPhI Annual Report 2019
13 Mar 2020
New modalities, new methods and new thinking to solve old problems
The CPhI Annual Report is a comprehensive and critically important publication that analyses key pharmaceutical trends and innovations forecast by our panel of world class experts. Running as a series of opinions and articles, the CPhI experts call upon their considerable commercial and technical acumen to prophesize the future direction, technologies, opportunities and threats in pharma. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.
Contents
CPhI’s Pharma Industry Rankings: Evaluation of current Pharma
Part 1. Innovation, AI and Regulation
Building Quality into Pharma Manufacturing, from Molecule to Medicine: Pharma 4.0
Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates
Chaos to Continual Improvement: Path to Harmonization
Ajaz Hussein PhD, The National Institute for Pharmaceutical Technology & Education, Inc., USA
Pharmaceutical Quality: Concepts, Misconceptions, Realities and Remedies
Girish Malhotra, President, Epcot International
Part 2. Biologics: Capacity and Biosimilars
Mammalian Biomanufacturing Industry Overview
Dawn M. Ecker, Director of Biotrak Database Services, Bioprocess Technology Group, BDO-USA, LLP
Patricia Seymour, Managing Director, Bioprocess Technology Group, BDO-USA, LLP
Biopharmaceutical Therapies And Biosimilars: Not Your Father’s Medication
Emil W. Ciurczak, Doramaxx Consulting
Part 3. Biologics: Advanced Therapies and China
Trends in Chinese Biopharmaceutical Manufacturing, Contract Manufacturing
Vicky Qing Xia, Bioplan Associates, INC. Rockville, MD
New Developments in Bioprocessing Development & Manufacturing
Michiel E. Ultee, PhD, Ulteemit Bioconsulting, LLC
Part 4. Contract Services, new Modalities and Breakthroughs
Increase in Drug Approvals and Priority Review Shows the Future Is Bright for the CMO Industry
Adam Bradbury Industry Analyst, Pharmsource, a GlobalData product
Patient Centricity: The New Nexus for CDMOs
Stuart E. Needleman, Chief Commercial Officer, Piramal Pharma Solutions
Newer Drugs will Require a New Way of Manufacturing Centred on the Patient
Peter Soelkner, Managing Director, Vetter Pharma International GMBH
Related Content
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation